Developing endovascular repair devices to treat abdominal aortic aneurysms
Location: United States, California, Santa Rosa
Total raised: $190M
Investors 4
| Date | Name | Website |
| 06.07.2021 | New Enterp... | nea.com |
| - | CRG | crglp.com |
| - | Kaiser Per... | kpventures... |
| - | Delphi Ven... | delphivent... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 18.11.2013 | Series E | $40M | - |
| 04.06.2012 | Series D | $60M | - |
| 14.07.2010 | - | $60M | - |
| 20.11.2009 | Series B | $30M | - |
Mentions in press and media 14
| Date | Title | Description |
| 04.04.2014 | TriVascular Technologies sets price range for $98M IPO | TriVascular Technologies said it could raise as much as $98 million from its planned initial public offering after setting the per-share price range at $13-$15. That would set the top end of the 6.5-million-share offering at $97.5 million, ... |
| 11.03.2014 | TriVascular Tech aims for $100M IPO | California medical device maker TriVascular Technologies is looking to raise as much as $100 million through its initial public offering, the details of which have yet to be finalized. The stent graft maker said in registration documents th... |
| 18.11.2013 | TriVascular Closes $40M Series E Equity Financing | TriVascular, Inc., a Santa Rosa, CA-based has developed design and manufacturing technologies for endovascular aortic repair (EVAR), closed a $40m Series E equity financing. Backers included existing investors New Enterprise Associates, Del... |
| 18.11.2013 | TriVascular raises $40M Series E round | TriVascular Inc. said it’s added another $40 million to its coffers in a Series E round it plans to use to expand its commercial footprint and " to fuel product pipeline and clinical research activities." Santa Rosa, Calif.-based ... |
| 18.11.2013 | TriVascular Secures $40M in Series E | SANTA, ROSA, CA, TriVascular, Inc. today announced the close of a $40 million Series E Preferred Stock equity financing. >> Click here for more funding data on TriVascular >> To export TriVascular funding data to PDF and Exc... |
| 04.06.2012 | TriVascular Secures $60M in Series D Financing | TriVascular, Inc., a Santa Rosa, California-based company that provides solutions for endovascular aortic repair (EVAR), has secured $60m in Series D equity financing, the initial tranche of which closed on June 1st. The round was led by ne... |
| 04.06.2012 | TriVascular Secures $60M in Series D Equity | SANTA ROSA, CA, New investor Kaiser Permanente Ventures, in partnership with the Redmile Group, led the round joining existing investors New Enterprise Associates, Delphi Ventures, MPM Capital, Kearny Venture Partners and Pinnacle Venture... |
| 11.11.2011 | GE Healthcare begins PMA process for 3D breast scanner | Regulatory Roundup | GE Healthcare (NYSE:GE) filed the first module of its pre-market approval application for the breast tomosynthesis option of its Senographe Essential system. The health care giant said the first submission included a device description and ... |
| 07.11.2011 | Stents: FDA approves TriVascular’s Ovation stent graft system | Regulatory Roundup | TriVascular Inc. landed U.S. humanitarian device exemption approval for its Ovation abdominal stent graft system used to repair abdominal aneurysms. The 20 mm Ovation system was approved by the FDA on Nov. 1 for use in patients with small i... |
| 13.10.2010 | Healthcare venture deals jump 33 percent in third quarter | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermin... |
Show more